Conversations with Innovators: Kenneth Ataga, MD
1,528 views · Published 22 February 2017 · 5:54 · Indexed 14 November 2026
Channel: American Society of Hematology · 2017 · Nonprofits & Activism
Kenneth Ataga, MD, with the University of North Carolina in Chapel discusses his program’s studying crizanlizumab to prevent pain crises in patients with sickle cell disease. Their study is covered in a Diffusion article by Dr. Michael DeBaun, featured in the March/April 2017 issue of The Hematologist.
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding